Hydroxyquinoline vaginal and Inotuzumab ozogamicin Intravenous
Determining the interaction of Hydroxyquinoline vaginal and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydroxyquinoline topical
Brand name: Trimo-San
Synonyms: Hydroxyquinoline (vaginal)
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydroxyquinoline vaginal-Inova
- Hydroxyquinoline vaginal-Inova 4/1 topical
- Hydroxyquinoline vaginal-Inova 8/2 topical
- Hydroxyquinoline vaginal-Inova ACT
- Hydroxyquinoline vaginal-Inrebic
- Hydroxyquinoline vaginal-Inspra
- Inotuzumab ozogamicin Intravenous-Hydroxyurea
- Inotuzumab ozogamicin Intravenous-Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Inotuzumab ozogamicin Intravenous-Hydroxyurea Capsules 500 mg
- Inotuzumab ozogamicin Intravenous-Hydroxyurea Tablets
- Inotuzumab ozogamicin Intravenous-Hydroxyzine
- Inotuzumab ozogamicin Intravenous-Hydroxyzine Capsules